Pfizer 8-K
CEO/CFO change
Interim CFO Cecile Guegan is appointed CFO and EVP, effective Nov. 1.
Filed 2026-11-03 16:19 ET
- 5.02 Officer/director change
- 9.01 Financial Statements and Exhibits
Summary
Cecile Guegan was appointed Pfizer’s CFO and Executive Vice President, effective 11/01/2026, after serving as interim CFO since 08/16/2026. Her annual compensation includes a $1.3M base salary and a target cash incentive of $1.3M, equal to 100% of her base salary and determined based on salary paid during the year.
The summary is written by an AI model reading the filing.
Model 005 · prompt v173 · 2026-11-03 23:47:14Z